Tag: remission

Reduced-Intensity Transplant Benefits Older Patients With AML

Among older patients with acute myeloid leukemia (AML), survival is significantly better when they undergo reduced-intensity condition (RIC) before receiving an allogeneic hematopoietic cell transplant...

Lower Steroid Dose Proves Effective for New-Onset ANCA Vasculitis

A reduced dose of prednisolone plus rituximab was as effective as a conventionally high dose in treating patients with newly diagnosed antineutrophil cytoplasmic antibody (ANCA)–associated...

FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis

The US Food and Drug Administration (FDA) has approved ozanimod (Zeposia) for adults with moderately to severely active ulcerative colitis (UC), the company has announced....

New Oral Protein Shows Promise for Ulcerative Colitis

A plant-based fusion protein is safe and effective for inducing favorable immune modulation in patients with mild to moderate ulcerative colitis with no immune suppression–side...

RA Experts Highlight Key Developments Over the Past Year

A massive Swedish cohort study suggesting that biologic agents reduce the known excess risk of lymphoma in patients with rheumatoid arthritis was hailed as one...

Patients With Early Arthritis May Need Tailored Treatments

Patients with early, undifferentiated arthritis may benefit from milder or stronger treatments, depending on the number of their risk factors for developing rheumatoid arthritis, researchers...

Slow Taper off Antimalarial Avoids Lupus Flare During Remission

Slowly tapering off – or remaining on – antimalarial medications can help prevent disease flare in patients with systemic lupus erythematosus (SLE) who’ve achieved clinical...

Psilocybin Delivers ‘Remarkable’ Relief in Severe Depression

Psilocybin, the psychedelic compound in “magic mushrooms,” rapidly improves symptoms and produces remission in as little as two sessions for patients with major depression, new...

Tofacitinib Retreatment Effective for Ulcerative Colitis

Retreatment with tofacitinib after a period of treatment interruption was well tolerated and effective in patients with ulcerative colitis who had shown a previous response...

New Rheumatoid Arthritis Drug May Help Tough Cases

By Dennis Thompson HealthDay Reporter MONDAY, Oct. 19, 2020 (HealthDay News) — A recently approved rheumatoid arthritis medication appears to be an effective...

Tailoring Treatment for Psoriasis, PsA, and Pregnancy

With an average age of diagnosis of 28 years, and one of two incidence peaks occurring at 15-30 years, psoriasis affects many women in the...

FDA Approves First Maintenance Therapy for AML

The US Food and Drug Administration (FDA) has approved an oral form of azacitidine (Onureg) for use as maintenance therapy for patients with acute myeloid...

ECT More Effective for Psychotic vs Nonpsychotic Depression?

For patients with psychotic depression, response to treatment, remission rates, and cognitive improvement are better following electroconvulsive therapy (ECT) than for patients with nonpsychotic depression,...

Brazilian Patient in HIV Remission, Negative Antibody Test

A 35-year-old Brazilian man who participated in a trial in which he received an intensified antiretroviral regimen plus supplemental vitamin B₃ for 48 weeks has joined...